We demonstrated that spermidine, which targets PINK1–parkin-mediated mitophagy, has beneficial effects on lupus mice: (a) improved endothelial function; (b) decreased inflammation; (c) enhanced mitophagy; and (d) did not decrease lupus disease activity. Here, PRKN is linked to systemic lupus erythematosus.